17 September 2018 - Deborah Wilkes
Premium
South African pharmaceutical company Aspen has agreed to divest its Nutritionals business to France's Lactalis for ZAR12.9 billion (USD877 million) in cash.
New to OTCToolbox?
This is available as part of an Annual Subscription to the OTCToolbox website.